https://www.selleckchem.com/pr....oducts/gsk-3008348-h
Cancer itself was the leading cause (54%) of the encounters. Over 20% of all encounters were classified as preventable, and half of those encounters were deemed unnecessary. TKI therapy, immunotherapy, and, to a lesser extent, chemotherapy are relatively small drivers of unplanned acute hospital care for patients with NSCLC. A significant share of unplanned hospital encounters may be prevented through proactive evidence-based initiatives. TKI therapy, immunotherapy, and, to a lesser extent, chemotherapy are relatively